For research use only. Not for therapeutic Use.
C215（Cat No.:I012396）is a selective, potent inhibitor of the protein kinase C (PKC) family, specifically targeting PKC-θ and PKC-ε isoforms. These isoforms are implicated in various signaling pathways, including immune cell activation, inflammation, and tumor progression. By modulating PKC activity, C215 has shown potential in regulating immune responses and controlling inflammatory diseases, as well as inhibiting tumor growth. It holds promise for the treatment of conditions like autoimmune disorders, chronic inflammation, and certain cancers. C215’s targeted approach provides a novel strategy for managing diseases driven by dysregulated PKC signaling.
| CAS Number | 912780-51-9 |
| Synonyms | N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine |
| Molecular Formula | C17H17Cl2N3 |
| Purity | ≥95% |
| IUPAC Name | N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine |
| InChI | InChI=1S/C17H17Cl2N3/c1-2-7-22-11-21-16-9-14(5-6-17(16)22)20-10-12-3-4-13(18)8-15(12)19/h3-6,8-9,11,20H,2,7,10H2,1H3 |
| InChIKey | PWEPSIFNTIQCNN-UHFFFAOYSA-N |
| SMILES | CCCN1C=NC2=C1C=CC(=C2)NCC3=C(C=C(C=C3)Cl)Cl |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
